Related Experiment Video

Updated: Aug 28, 2026

Procedures for Identifying Infectious Prions After Passage Through the Digestive System of an Avian Species
12:00

Procedures for Identifying Infectious Prions After Passage Through the Digestive System of an Avian Species

Published on: November 6, 2013

[Prion diseases in pediatrics]

I Sol-Caubel1, F Castela, V Brousse

  • 1Service de neuropédiatrie, hôpital Armand-Trousseau, Paris, France.

Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie
|April 7, 1999
PubMed

Insights

Prion diseases, like Creutzfeldt-Jakob disease (CJD), involve abnormal prion protein (PrP) accumulation. Research explores CJD transmission, particularly variant CJD linked to bovine spongiform encephalopathy, and the role of the PRNP gene.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Molecular Biology

Context:

  • Prion diseases are rare, fatal neurological disorders affecting humans and animals.
  • Creutzfeldt-Jakob disease (CJD) is the most common pediatric prion disease, often linked to growth hormone treatment.
  • Variant CJD (vCJD) emerged in the UK, with strong evidence linking it to bovine spongiform encephalopathy (BSE).

Purpose:

  • To review the current understanding of prion diseases, focusing on CJD and vCJD.
  • To discuss the role of prion protein (PrP) accumulation and the PRNP gene in disease pathogenesis.
  • To address unanswered questions regarding potential new pediatric vCJD cases and transmission routes.

Summary:

  • Prion diseases are characterized by the accumulation of misfolded prion protein (PrP) in the brain.
  • The PRNP gene, encoding PrP, and its mutations/polymorphisms are implicated in CJD.
  • The link between BSE and vCJD highlights potential zoonotic transmission, raising concerns about dietary exposure.

Impact:

  • Highlights the need for further research into prion disease mechanisms and transmission.
  • Informs public health strategies for preventing and managing prion disease outbreaks.
  • Underscores the importance of understanding the PRNP gene's role in susceptibility and disease progression.

More Related Videos

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans12:57

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans

Published on: January 8, 2015

Prion Safety Laboratory Swipe Test06:01

Prion Safety Laboratory Swipe Test

Published on: February 14, 2025

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Subviral Agents01:29

Subviral Agents

Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...